Skip to main content
Erschienen in: European Radiology 9/2017

08.02.2017 | Urogenital

An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer

verfasst von: Valeria Panebianco, Ettore De Berardinis, Giovanni Barchetti, Giuseppe Simone, Constantino Leonardo, Marcello Domenico Grompone, Maurizio Del Monte, Davide Carano, Michele Gallucci, James Catto, Carlo Catalano

Erschienen in: European Radiology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Our goal is to determine the ability of multi-parametric magnetic resonance imaging (mpMRI) to differentiate muscle invasive bladder cancer (MIBC) from non-muscle invasive bladder cancer (NMIBC).

Methods

Patients underwent mpMRI before tumour resection. Four MRI sets, i.e. T2-weighted (T2W) + perfusion-weighted imaging (PWI), T2W plus diffusion-weighted imaging (DWI), T2W + DWI + PWI, and T2W + DWI + PWI + dif-fusion tensor imaging (DTI) were interpreted qualitatively by two radiologists, blinded to histology results. PWI, DWI and DTI were also analysed quantitatively. Accuracy was determined using histopathology as the reference standard.

Results

A total of 82 tumours were analysed. Ninety-six percent of T1-labeled tumours by the T2W + DWI + PWI image set were confirmed to be NMIBC at histopathology. Overall accuracy of the complete mpMRI protocol was 94% in differentiating NMIBC from MIBC. PWI, DWI and DTI quantitative parameters were shown to be significantly different in cancerous versus non-cancerous areas within the bladder wall in T2-labelled lesions.

Conclusions

MpMRI with DWI and DTI appears a reliable staging tool for bladder cancer. If our data are validated, then mpMRI could precede cystoscopic resection to allow a faster recognition of MIBC and accelerated treatment pathways.

Key Points

A critical step in BCa staging is to differentiate NMIBC from MIBC.
Morphological and functional sequences are reliable techniques in differentiating NMIBC from MIBC.
Diffusion tensor imaging could be an additional tool in BCa staging.
Literatur
1.
Zurück zum Zitat Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A (2014) International variations in bladder cancer incidence and mortality. Eur Urol 66:59–73CrossRefPubMed Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A (2014) International variations in bladder cancer incidence and mortality. Eur Urol 66:59–73CrossRefPubMed
2.
Zurück zum Zitat Svatek RS, Hollenbeck BK, Holmang S, Lee R, Kim SP, Stenzl A et al (2014) The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 66:253–62CrossRefPubMed Svatek RS, Hollenbeck BK, Holmang S, Lee R, Kim SP, Stenzl A et al (2014) The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 66:253–62CrossRefPubMed
3.
Zurück zum Zitat Cumberbatch MGK, Cox A, Teare D, Catto JWF (2015) Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis. JAMA Oncol 1:1282–90CrossRefPubMed Cumberbatch MGK, Cox A, Teare D, Catto JWF (2015) Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis. JAMA Oncol 1:1282–90CrossRefPubMed
4.
Zurück zum Zitat Cumberbatch MG, Rota M, Catto JWF, La Vecchia C (2016) The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 70:458–66CrossRefPubMed Cumberbatch MG, Rota M, Catto JWF, La Vecchia C (2016) The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 70:458–66CrossRefPubMed
5.
Zurück zum Zitat Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2016. Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2016.
6.
Zurück zum Zitat Linton KD, Rosario DJ, Thomas F, Rubin N, Goepel JR, Abbod MF et al (2013) Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance. J Urol 189:828–33CrossRefPubMed Linton KD, Rosario DJ, Thomas F, Rubin N, Goepel JR, Abbod MF et al (2013) Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance. J Urol 189:828–33CrossRefPubMed
7.
Zurück zum Zitat Thomas F, Noon AP, Rubin N, Goepel JR, Catto JWF (2013) Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer. Eur Urol 63:145–54CrossRefPubMed Thomas F, Noon AP, Rubin N, Goepel JR, Catto JWF (2013) Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer. Eur Urol 63:145–54CrossRefPubMed
8.
Zurück zum Zitat Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A et al (2010) An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 57:60–70CrossRefPubMed Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A et al (2010) An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 57:60–70CrossRefPubMed
9.
Zurück zum Zitat Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523–31CrossRefPubMed Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523–31CrossRefPubMed
10.
Zurück zum Zitat Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H (1994) Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 193:239–45CrossRefPubMed Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H (1994) Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 193:239–45CrossRefPubMed
11.
Zurück zum Zitat Hayashi N, Tochigi H, Shiraishi T, Takeda K, Kawamura J (2000) A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int 85:32–6CrossRefPubMed Hayashi N, Tochigi H, Shiraishi T, Takeda K, Kawamura J (2000) A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int 85:32–6CrossRefPubMed
12.
Zurück zum Zitat Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K et al (2005) Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 184:121–7CrossRefPubMed Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K et al (2005) Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 184:121–7CrossRefPubMed
13.
Zurück zum Zitat Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T et al (2009) Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology 251:112–21CrossRefPubMed Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T et al (2009) Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology 251:112–21CrossRefPubMed
14.
Zurück zum Zitat Naish JH, McGrath DM, Bains LJ, Passera K, Roberts C, Watson Y et al (2011) Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer. Magn Reson Med 66:219–26CrossRefPubMed Naish JH, McGrath DM, Bains LJ, Passera K, Roberts C, Watson Y et al (2011) Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer. Magn Reson Med 66:219–26CrossRefPubMed
15.
Zurück zum Zitat Lankester KJ, Taylor JN, Stirling JJ, Boxall J, d’Arcy JA, Collins DJ et al (2007) Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors. J Magn Reson Imaging 25:796–805CrossRefPubMed Lankester KJ, Taylor JN, Stirling JJ, Boxall J, d’Arcy JA, Collins DJ et al (2007) Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors. J Magn Reson Imaging 25:796–805CrossRefPubMed
16.
Zurück zum Zitat Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A (2009) Longer wait times increase overall mortality in patients with bladder cancer. J Urol 182:1318–24CrossRefPubMed Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A (2009) Longer wait times increase overall mortality in patients with bladder cancer. J Urol 182:1318–24CrossRefPubMed
17.
Zurück zum Zitat Fahmy NM, Mahmud S, Aprikian AG (2006) Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 50:1176–82CrossRefPubMed Fahmy NM, Mahmud S, Aprikian AG (2006) Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 50:1176–82CrossRefPubMed
18.
Zurück zum Zitat Blaschke S, Koenig F, Schostak M. Hematogenous Tumor Cell Spread Following Standard Transurethral Resection of Bladder Carcinoma. Vol. 70, European urology. Switzerland; 2016. p. 544–5. Blaschke S, Koenig F, Schostak M. Hematogenous Tumor Cell Spread Following Standard Transurethral Resection of Bladder Carcinoma. Vol. 70, European urology. Switzerland; 2016. p. 544–5.
19.
Zurück zum Zitat de Haas RJ, Steyvers MJ, Futterer JJ (2014) Multiparametric MRI of the bladder: ready for clinical routine? AJR Am J Roentgenol 202:1187–95CrossRefPubMed de Haas RJ, Steyvers MJ, Futterer JJ (2014) Multiparametric MRI of the bladder: ready for clinical routine? AJR Am J Roentgenol 202:1187–95CrossRefPubMed
20.
Zurück zum Zitat Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T (2009) Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 251:415–21CrossRefPubMed Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T (2009) Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 251:415–21CrossRefPubMed
21.
Zurück zum Zitat Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Unal O (2011) The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol 84:875–82CrossRefPubMedPubMedCentral Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Unal O (2011) The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol 84:875–82CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Wang H-J, Pui MH, Guan J, Li S-R, Lin J-H, Pan B, et al. (2016) Comparison of early submucosal enhancement and tumor stalk in staging bladder urothelial carcinoma. AJR Am J Roentgenol.1–7 Wang H-J, Pui MH, Guan J, Li S-R, Lin J-H, Pan B, et al. (2016) Comparison of early submucosal enhancement and tumor stalk in staging bladder urothelial carcinoma. AJR Am J Roentgenol.1–7
23.
Zurück zum Zitat Wang H, Pui MH, Guo Y, Li S, Guan J, Zhang X et al (2015) Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. AJR Am J Roentgenol 204:330–4CrossRefPubMed Wang H, Pui MH, Guo Y, Li S, Guan J, Zhang X et al (2015) Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. AJR Am J Roentgenol 204:330–4CrossRefPubMed
24.
Zurück zum Zitat Zhang L, Liu A, Zhang T, Song Q, Wei Q, Wang H (2015) Use of diffusion tensor imaging in assessing superficial myometrial invasion by endometrial carcinoma: a preliminary study. Acta Radiol 56:1273–80CrossRefPubMed Zhang L, Liu A, Zhang T, Song Q, Wei Q, Wang H (2015) Use of diffusion tensor imaging in assessing superficial myometrial invasion by endometrial carcinoma: a preliminary study. Acta Radiol 56:1273–80CrossRefPubMed
25.
Zurück zum Zitat Panebianco V, Barchetti F, Sciarra A, Marcantonio A, Zini C, Salciccia S et al (2013) In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging. Eur J Radiol 82:1677–82CrossRefPubMed Panebianco V, Barchetti F, Sciarra A, Marcantonio A, Zini C, Salciccia S et al (2013) In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging. Eur J Radiol 82:1677–82CrossRefPubMed
Metadaten
Titel
An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer
verfasst von
Valeria Panebianco
Ettore De Berardinis
Giovanni Barchetti
Giuseppe Simone
Constantino Leonardo
Marcello Domenico Grompone
Maurizio Del Monte
Davide Carano
Michele Gallucci
James Catto
Carlo Catalano
Publikationsdatum
08.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 9/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-4758-3

Weitere Artikel der Ausgabe 9/2017

European Radiology 9/2017 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.